Lemairamin

Preclinical Research

Also known as: WGX-50, Raubasine analogue

Educational Content Only

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The FDA has not evaluated many of the peptides discussed here. Always consult a licensed healthcare provider before making any health decisions.

Overview

Lemairamin is a plant-derived alkaloid (isolated as WGX-50 from Evodia lepta) studied in the context of neuroprotection and neurological aging. Research in animal models has examined its potential to protect neurons from amyloid-beta toxicity and oxidative stress, with interest in Alzheimer's disease research.

Possible Uses

The following areas have been examined in research contexts. This does not constitute medical advice or imply proven efficacy in humans.

Cognitive Enhancement
Anti-Aging & Longevity

Mechanism of Action

Research suggests lemairamin may exert neuroprotective effects through antioxidant mechanisms, modulation of neuroinflammatory pathways, and potential inhibition of tau phosphorylation. Specific receptor binding targets are under investigation in preclinical settings.

Safety Notes

All research is preclinical. No human clinical trials. Not FDA-approved.

Want to learn more?

Ask Research Chat about Lemairamin

Research Profile

Half-Life

Not well characterized

Administration

oral (in animal studies)

Legal Status (US)

Research compound. Not FDA-approved.

13 indexed research passages

Related Peptides

Oxytocin

Oxytocin is a nine-amino acid neuropeptide hormone produced in the hypothalamus and released by the posterior pituitary, studied extensively for its roles in social bonding, trust, maternal behavior, uterine contraction, and lactation. It is FDA-approved for obstetric indications and has been extensively studied in clinical contexts including autism spectrum disorder and social anxiety.

P21

P21 is a short synthetic peptide derived from humanin with modifications intended to enhance potency and stability. Research has examined its potential roles in neuroprotection, cognitive function, and cellular survival signaling, particularly in the context of Alzheimer's disease models and age-related cognitive decline.

Tropisetron

Tropisetron is a 5-HT3 receptor antagonist and alpha7 nicotinic acetylcholine receptor agonist approved in various countries for chemotherapy-induced nausea. Research has also examined its potential roles in pain management, fibromyalgia, and cognitive enhancement through its dual receptor pharmacology.

9-ME-BC

9-ME-BC is a synthetic β-carboline alkaloid with structural similarity to naturally occurring harman compounds. Research in animal models has examined its potential neuroprotective, dopaminergic, and pro-cognitive properties, with particular interest in its ability to promote neurogenesis and dendritic growth in dopaminergic neurons.